Skip to main content
Springer Nature Link
Account
Fig. 1 | Current Hematologic Malignancy Reports

Fig. 1

From: Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma

Fig. 1The alternative text for this image may have been generated using AI.

Suggested pathway for front-line management of DLBCL. DLBCL, diffuse large B cell lymphoma; PMBCL, Primary mediastinal B cell lymphoma; PCNSL, Primary central nervous system lymphoma; R-CHOP, rituximab, cyclophosphamide, vincristine, prednisolone; CT NCAP, Computed tomography neck, chest, abdomen and pelvis; DA-EPOCH-R, dose-adjusted etoposide plus rituximab, cyclophosphamide, vincristine, prednisolone; R-GCVP, rituximab, gemcitabine, cyclophosphamide, vincristine, prednisolone; PET-CT, 18F-fluorodeoxyglucose enhanced positron emission tomography with concurrent low dose computed tomography; EF, left ventricular ejection fraction

Back to article page